首頁 > 市場調查報告書 > 醫療設備

體外診斷感染疾病

市場調查報告書

商品編碼

1662352

2025 年性行為感染傳染病 (STD) 診斷全球市場報告

STD Diagnostics Global Market Report 2025

出版日期: 2025年02月25日 | 出版商:

The Business Research Company | 英文 200 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄

預計未來幾年性行為感染傳染病（STD）診斷的市場規模將快速成長。到 2029 年，這一數字將成長至 162.1 億美元，複合年成長率為 10.5%。預測期內的成長可歸因於個人化醫療的趨勢、醫療保健服務的改善、人口健康策略、遠端醫療和數位健康以及性行為感染傳染病盛行率的上升。預測期內的關鍵趨勢包括即時診斷、家庭檢測套組、多重檢測、有針對性的行銷和推廣、暴露前預防計劃以及發病率的上升。

性行為感染傳染病的流行是性行為感染傳染病（STD）診斷市場向前發展的關鍵促進因素。性病是透過性接觸傳播的感染疾病，是全球性的健康問題。 2022年，世界衛生組織（WHO）報告稱，全球每天發生超過一百萬例性行為感染傳染病，包括披衣菌感染、淋病、梅毒和滴蟲病，每年約有3.74億新感染病例。性傳染病發生率的不斷上升凸顯了性行為感染傳染病（STD）診斷在有效分析和檢測中的關鍵作用，從而推動了市場的成長。

預計未來幾年醫療保健支出的增加將推動性行為感染傳染病 (STD) 診斷市場的成長。醫療保健支出是指特定醫療保健系統或經濟體在特定時期內用於醫療保健服務及相關商品和活動的總金額。這項醫療保健支出與性行為感染傳染病 (STD) 診斷相關，因為它代表了對預防保健的策略性投資，解決了公共衛生優先事項，並有助於個人和社區層面的整體健康和福祉。例如，2024 年 5 月，英國政府機構國家統計局報告稱，2022 年至 2023 年醫療保健總支出名義上將成長 5.6%，與 2022 年 0.9% 的增幅相比有顯著成長。因此，醫療保健支出的增加正在推動性行為感染傳染病 (STD) 診斷市場的成長。

全球性行為感染傳染病 (STD) 診斷市場的 PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素、限制因素）
最終用途產業分析
全球性行為感染傳染病 (STD) 診斷市場：成長率分析
全球性行為感染傳染病 (STD) 診斷市場表現：規模與成長，2019-2024 年
全球性行為感染傳染病 (STD) 診斷市場預測：規模與成長，2024-2029 年，2034 年
全球性行為感染傳染病 (STD) 診斷總目標市場 (TAM)

第6章市場細分

全球性行為感染傳染病 (STD) 診斷市場類型、績效及預測，2019-2024、2024-2029、2034
披衣菌感染檢測
梅毒檢測
淋病檢查
單純皰疹病毒檢測
人類乳突病毒檢測
人類免疫力缺乏 ( HIV ) 檢測
軟性下疳檢查
其他
全球性行為感染傳染病 (STD) 診斷市場（按檢測地點、表現和預測）2019-2024、2024-2029、2034
實驗室測試
照護現場（PoC）測試
全球性行為感染傳染病 (STD) 診斷市場（按最終用戶、績效和預測），2019-2024 年、2024-2029 年、2034 年
醫院和診所
診斷中心
居家護理
全球性行為感染傳染病 (STD) 診斷市場：披衣菌感染檢測細分類型、效能和預測，2019-2024 年、2024-2029 年、2034 年
核酸增幅檢查（NAAT）
抗原檢測
全球性行為感染傳染病 (STD) 診斷市場：梅毒檢測細分類型、表現與預測，2019-2024 年、2024-2029 年、2034 年
快速血漿再生 (RPR) 檢測
梅毒螺旋體檢測
全球性行為感染傳染病 (STD) 診斷市場：淋病檢測細分類型、效能和預測，2019-2024 年、2024-2029 年、2034 年
核酸增幅檢查（NAAT）
文化
全球性行為感染傳染病 (STD) 診斷市場：單純皰疹病毒檢測細分類型、效能和預測，2019-2024 年、2024-2029 年、2034 年
PCR 檢測
血清學檢測
全球性行為感染傳染病 (STD) 診斷市場：人類乳突病毒檢測細分（按類型、效能和預測），2019-2024 年、2024-2029 年、2034 年
HPV DNA 檢測
HPV RNA 檢測
全球性行為感染傳染病 (STD) 診斷市場：人類免疫力缺乏病毒檢測按類型、效能和預測細分，2019-2024 年、2024-2029 年、2034 年
抗體檢測
抗原或抗體檢測
核酸檢測 (NAT)
全球性行為感染傳染病 (STD) 診斷市場：軟性下疳檢測細分類型、效能和預測，2019-2024 年、2024-2029 年、2034 年
文化
核酸檢測
全球性行為感染傳染病 (STD) 診斷市場：按類型、實際和預測分類的其他細分市場，2019-2024 年、2024-2029 年、2034 年
各種新測試

第7章區域和國家分析

全球性行為感染傳染病 (STD) 診斷市場各地區、績效及預測，2019-2024、2024-2029、2034
全球性行為感染傳染病 (STD) 診斷市場（按國家/地區分類）、績效及預測，2019-2024 年、2024-2029 年、2034 年

第8章亞太市場

第9章：中國市場

第10章印度市場

第11章日本市場

第12章澳洲市場

第13章印尼市場

第14章韓國市場

第15章西歐市場

第16章英國市場

第 17 章德國市場

第 18 章法國市場

第 19 章：義大利市場

第 20 章：西班牙市場

第21章東歐市場

第22章俄羅斯市場

第23章北美市場

第24章美國市場

第 25 章：加拿大市場

第26章南美洲市場

第 27 章：巴西市場

第28章中東市場

第 29 章：非洲市場

第 30 章競爭格局與公司概況

性行為感染傳染病 (STD) 診斷市場：競爭格局
性行為感染傳染病 (STD) 診斷市場：公司簡介
- Siemens AG Overview, Products and Services, Strategy and Financial Analysis
- Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- Qiagen Inc. Overview, Products and Services, Strategy and Financial Analysis
- Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
- F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

第31章其他大型創新企業

Hologic Inc.
Bio-Rad Laboratories Inc.
Becton Dickinson and Company
Thermo Fisher Scientific Inc.
Biocartis NV
Trinity Biotech PLC
Binx Health Inc.
NOWDiagnostics Inc.
Atlas Genetics Ltd.
BioFire Diagnostics LLC
BioMerieux SA
Chembio Diagnostic Systems Inc.
Corgenix Medical Corporation
Creative Diagnostics
Curetis AG

第 32 章全球市場競爭基準化分析與儀表板

第33章重大併購

第 34 章近期市場趨勢

第 35 章高市場潛力國家、細分市場與策略

2029 年性行為感染傳染病 (STD) 診斷市場：提供新機會的國家
2029 年性行為感染傳染病 (STD) 診斷市場：提供新機會的細分市場
性行為感染傳染病 (STD) 診斷市場 2029：成長策略
- 基於市場趨勢的策略
- 競爭對手的策略

第 36 章附錄

簡介目錄

Product Code: r22987

Sexually Transmitted Diseases (STDs) diagnostics encompass the examination and identification of infectious conditions transmitted through sexual contact. These diagnostic procedures are essential in determining the presence of STDs within an individual.

The primary categories of STD diagnostics include chlamydia, syphilis, gonorrhea, herpes simplex virus, human papillomavirus, human immunodeficiency virus, chancroid, and other tests performed in laboratory and point-of-care settings. Chlamydia testing involves a urine sample analysis to detect infection. This specific test is employed for identifying chlamydia infections, a common bacterial sexually transmitted infection (STI) transmitted through various forms of sexual contact or genital exposure. These STD diagnostic procedures find application in hospitals, clinics, diagnostic centers, and homecare settings.

The STD diagnostics market research report is one of a series of new reports from The Business Research Company that provides STD diagnostics market statistics, including STD diagnostics industry global market size, regional shares, competitors with a STD diagnostics market share, detailed STD diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the STD diagnostics industry. This STD diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The STD diagnostics market size has grown strongly in recent years. It will grow from $9.93 billion in 2024 to $10.86 billion in 2025 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be attributed to epidemiological trends, healthcare infrastructure development, pharmaceutical developments, sexual education programs, demographic shifts.

The STD diagnostics market size is expected to see rapid growth in the next few years. It will grow to $16.21 billion in 2029 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to personalized medicine trends, healthcare access improvements, population health strategies, telemedicine and digital health, rising incidence of STDs. Major trends in the forecast period include point-of-care testing (POCT) advancements, home testing kits, multiplex testing, targeted marketing and outreach, pre-exposure prophylaxis (prep) programs, rising incidence rates.

The escalating prevalence of sexually transmitted diseases (STDs) is a significant driver propelling the STD diagnostics market forward. STDs, infectious diseases transmitted through sexual contact, have become a global health concern. In 2022, the World Health Organization reported that over 1 million sexually transmitted infections are acquired daily worldwide, with approximately 374 million new infections annually, including chlamydia, gonorrhea, syphilis, and trichomoniasis. The rising incidence of STDs underscores the critical role of STD diagnostics in efficient analysis and testing, driving the market's growth.

The increasing healthcare expenditure is anticipated to drive the growth of the STD diagnostics market in the future. Healthcare expenditure refers to the overall amount of money spent on healthcare services, related goods, and activities within a specific healthcare system or economy over a defined period. This expenditure is relevant to STD diagnostics as it signifies a strategic investment in preventive healthcare, addresses public health priorities, and contributes to overall health and well-being at both individual and community levels. For example, in May 2024, a report from the Office for National Statistics, a UK-based government department, indicated that total healthcare expenditure rose by 5.6% in nominal terms from 2022 to 2023, marking a significant increase compared to the 0.9% growth recorded in 2022. Thus, the rise in healthcare expenditures is fueling the growth of the STD diagnostics market.

The advancement of STD diagnostics is a significant trend within the STD diagnostic market. Major players are enhancing testing facilities and techniques to facilitate quicker and more accurate diagnoses of sexually transmitted diseases. For example, in May 2022, BD (Becton, Dickinson, and Company), a US-based medical technology firm, launched a fully automated, high-throughput molecular diagnostics platform for infectious diseases called the BD CORTM MX/PX System. This platform integrates and automates the molecular laboratory workflow, from sample processing to the delivery of diagnostic test results. The first test available on this new platform is the BD CTGCTV2 molecular assay, which is a single test capable of identifying the three most prevalent non-viral STIs (sexually transmitted infections): Chlamydia trachomatis (CT), Neisseria gonorrhoeae (GC), and Trichomonas vaginalis (TV).

Key companies in the STD diagnostics market are focusing on developing innovative products, such as real-time PCR kits, to meet unmet medical needs and improve diagnostic capabilities. A real-time PCR kit consists of a collection of reagents utilized for conducting real-time polymerase chain reaction (qPCR), a sensitive and commonly employed technique for detecting and quantifying specific nucleic acid sequences. For instance, in March 2023, Jiangsu Bioperfectus Technologies Co. Ltd., a China-based research and development company, introduced the Mycoplasma Hominis Real Time PCR Kit and the Treponema Pallidum Real Time PCR Kit, specifically designed for detecting Mycoplasma hominis and Treponema pallidum. These kits offer high sensitivity and specificity, user-friendliness, rapid turnaround times, and the capability to detect multiple pathogens in a single test.

In February 2024, Thyrocare, an India-based healthcare company, acquired Think Health Care for an undisclosed amount. With this acquisition, Thyrocare aims to strategically enhance its service offerings and market reach, especially in the home healthcare segment. Think Health Care is an India-based company specializing in diagnostic and preventive healthcare, known for providing at-home ECG services.

Major companies operating in the STD diagnostics market are Siemens AG, Abbott Laboratories, Qiagen Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Hologic Inc., Bio-Rad Laboratories Inc., Becton Dickinson and Company, Thermo Fisher Scientific Inc., Biocartis NV, Trinity Biotech PLC, Binx Health Inc., NOWDiagnostics Inc., Atlas Genetics Ltd., BioFire Diagnostics LLC, BioMerieux SA, Chembio Diagnostic Systems Inc., Corgenix Medical Corporation, Creative Diagnostics, Curetis AG, Daktari Diagnostics, Enzo Biochem Inc., Fujirebio Diagnostics Inc., GenePOC Inc., GenMark Diagnostics Inc., Grifols Diagnostic Solutions Inc., Hain Lifescience GmbH, InDevR Inc., Karius Inc., Luminex Corporation, Meridian Bioscience Inc., Mesa Biotech Inc., Mobidiag Oy

North America was the largest region in the STD diagnostics market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the std diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the std diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The STD diagnostics market consists of revenues earned by entities by providing STD diagnostics tests such as cultural/isolated tests of organisms, molecular tests, and immunology assays. The market value includes the value of related goods sold by the service provider or included within the service offering. The STD diagnostics market also includes sales of thermal cyclers, PCR, lateral flow readers - immuno chromatographic assays, flow cytometers, differential light scattering machines, absorbance microplate readers, phone chips, and rapid diagnostic kits which are used in providing STD diagnostic services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

STD Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on std diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for std diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The std diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Chlamydia Testing; Syphilis Testing; Gonorrhea Testing; Herpes Simplex Virus Testing; Human Papilloma Virus Testing; Human Immunodeficiency Virus Testing; Chancroid Testing; Other Types
2) By Location Of Testing: Laboratory Testing; Point Of Care (PoC) Testing
3) By End-User: Hospitals And Clinics; Diagnostic Centers; Homecare
Subsegments:
1) By Chlamydia Testing: Nucleic Acid Amplification Tests (NAAT); Antigen Tests
2) By Syphilis Testing: Rapid Plasma Reagin (RPR) Tests; Treponemal Tests
3) By Gonorrhea Testing: Nucleic Acid Amplification Tests (NAAT); Culture Tests
4) By Herpes Simplex Virus Testing: PCR Tests; Serological Tests
5) By Human Papilloma Virus Testing: HPV DNA Tests; HPV RNA Tests
6) By Human Immunodeficiency Virus Testing: Antibody Tests; Antigen Or Antibody Tests; Nucleic Acid Tests (NAT)
7) By Chancroid Testing: Culture Tests; Nucleic Acid Tests
8) By Other Types: Various Emerging Tests
Companies Mentioned: Siemens AG; Abbott Laboratories; Qiagen Inc.; Danaher Corporation; F. Hoffmann-La Roche AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

1. Executive Summary

2. STD Diagnostics Market Characteristics

3. STD Diagnostics Market Trends And Strategies

4. STD Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global STD Diagnostics Growth Analysis And Strategic Analysis Framework

5.1. Global STD Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global STD Diagnostics Market Growth Rate Analysis
5.4. Global STD Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global STD Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global STD Diagnostics Total Addressable Market (TAM)

6. STD Diagnostics Market Segmentation

6.1. Global STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Chlamydia Testing
Syphilis Testing
Gonorrhea Testing
Herpes Simplex Virus Testing
Human Papilloma Virus Testing
Human Immunodeficiency Virus Testing
Chancroid Testing
Other Types
6.2. Global STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Laboratory Testing
Point Of Care (PoC) Testing
6.3. Global STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Clinics
Diagnostic Centers
Homecare
6.4. Global STD Diagnostics Market, Sub-Segmentation Of Chlamydia Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Nucleic Acid Amplification Tests (NAAT)
Antigen Tests
6.5. Global STD Diagnostics Market, Sub-Segmentation Of Syphilis Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Rapid Plasma Reagin (RPR) Tests
Treponemal Tests
6.6. Global STD Diagnostics Market, Sub-Segmentation Of Gonorrhea Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Nucleic Acid Amplification Tests (NAAT)
Culture Tests
6.7. Global STD Diagnostics Market, Sub-Segmentation Of Herpes Simplex Virus Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
PCR Tests
Serological Tests
6.8. Global STD Diagnostics Market, Sub-Segmentation Of Human Papilloma Virus Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
HPV DNA Tests
HPV RNA Tests
6.9. Global STD Diagnostics Market, Sub-Segmentation Of Human Immunodeficiency Virus Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Antibody Tests
Antigen Or Antibody Tests
Nucleic Acid Tests (NAT)
6.10. Global STD Diagnostics Market, Sub-Segmentation Of Chancroid Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Culture Tests
Nucleic Acid Tests
6.11. Global STD Diagnostics Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Various Emerging Tests

7. STD Diagnostics Market Regional And Country Analysis

7.1. Global STD Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global STD Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific STD Diagnostics Market

8.1. Asia-Pacific STD Diagnostics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China STD Diagnostics Market

9.1. China STD Diagnostics Market Overview
9.2. China STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India STD Diagnostics Market

10.1. India STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan STD Diagnostics Market

11.1. Japan STD Diagnostics Market Overview
11.2. Japan STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia STD Diagnostics Market

12.1. Australia STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia STD Diagnostics Market

13.1. Indonesia STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea STD Diagnostics Market

14.1. South Korea STD Diagnostics Market Overview
14.2. South Korea STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe STD Diagnostics Market

15.1. Western Europe STD Diagnostics Market Overview
15.2. Western Europe STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK STD Diagnostics Market

16.1. UK STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany STD Diagnostics Market

17.1. Germany STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France STD Diagnostics Market

18.1. France STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy STD Diagnostics Market

19.1. Italy STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain STD Diagnostics Market

20.1. Spain STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe STD Diagnostics Market

21.1. Eastern Europe STD Diagnostics Market Overview
21.2. Eastern Europe STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia STD Diagnostics Market

22.1. Russia STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America STD Diagnostics Market

23.1. North America STD Diagnostics Market Overview
23.2. North America STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA STD Diagnostics Market

24.1. USA STD Diagnostics Market Overview
24.2. USA STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada STD Diagnostics Market

25.1. Canada STD Diagnostics Market Overview
25.2. Canada STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America STD Diagnostics Market

26.1. South America STD Diagnostics Market Overview
26.2. South America STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil STD Diagnostics Market

27.1. Brazil STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East STD Diagnostics Market

28.1. Middle East STD Diagnostics Market Overview
28.2. Middle East STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa STD Diagnostics Market

29.1. Africa STD Diagnostics Market Overview
29.2. Africa STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. STD Diagnostics Market Competitive Landscape And Company Profiles

30.1. STD Diagnostics Market Competitive Landscape
30.2. STD Diagnostics Market Company Profiles
- 30.2.1. Siemens AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Qiagen Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

31. STD Diagnostics Market Other Major And Innovative Companies

31.1. Hologic Inc.
31.2. Bio-Rad Laboratories Inc.
31.3. Becton Dickinson and Company
31.4. Thermo Fisher Scientific Inc.
31.5. Biocartis NV
31.6. Trinity Biotech PLC
31.7. Binx Health Inc.
31.8. NOWDiagnostics Inc.
31.9. Atlas Genetics Ltd.
31.10. BioFire Diagnostics LLC
31.11. BioMerieux SA
31.12. Chembio Diagnostic Systems Inc.
31.13. Corgenix Medical Corporation
31.14. Creative Diagnostics
31.15. Curetis AG

32. Global STD Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The STD Diagnostics Market

34. Recent Developments In The STD Diagnostics Market

35. STD Diagnostics Market High Potential Countries, Segments and Strategies

35.1 STD Diagnostics Market In 2029 - Countries Offering Most New Opportunities
35.2 STD Diagnostics Market In 2029 - Segments Offering Most New Opportunities
35.3 STD Diagnostics Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies